Mark Key, MD, is a board-certified family medicine physician with a comprehensive approach to health that spans full-scope primary care, longevity medicine, and the specialized needs of high-performance athletes
Researchers continue investigating BPC-157 for its potential role in peptide signaling, angiogenesis, extracellular matrix biology, and regenerative research models
"Unlike GLP-1 medications, phentermine doesn't meaningfully affect how your body processes food
Yet as emphasized earlier, the former comes at the cost of an increase in cortisol levels and other hunger hormones
North America leads the GLP-1 medications market, generating 77.72% of global revenue for GLP-1 receptor agonists and 75.5% for GLP-1 weight-loss medications in 2024